Crescent Biopharma, Inc. (CBIO)
Market Closed
27 Jul, 20:00
$
16. 93
+0.63
+3.865%
$
436.46M Market Cap
- P/E Ratio
- Div Yield
259,625 Volume
- Eps
$ 16.3
Previous Close Want to track CBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Crescent Biopharma, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 300,000 | $3.56M | $4.51M | $957,000 | 26.9% |
| NM Nir Messafi Deep Track Capita LLP | 453,686 | $7.32M | $6.7M | -$618,600.86 | -8.45% |
 Regan O'Neill Burkehill Global Management LP | 74,000 | $844,340 | $1.11M | $268,013.2 | 31.74% |
 Drew Phillips Fortitude Family Office LLC | 40 | $735 | $602 | -$133 | -18.1% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 4 | $73 | $60.2 | -$12.8 | -17.53% |
 Ilko Menkov Vestal Point Capita LLP | 1.5M | $17.79M | $24.14M | $6.34M | 35.67% |
 BRIANNE SHERGILL Exome Asset Management LLC | 153,191 | $2.81M | $2.45M | -$359,999.19 | -12.79% |
